0 items USD 0.00Search
Your search for "hjresearch global dysthymia clinical trial industry market research 2019" gave back 1540763 results.
Dysthymia is often characterized by chronic depression. Symptoms of dysthymia are the same as for depression and usually not as severe as major...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Dysthymia is often characterized by chronic depression. Symptoms of dysthymia are the same as for depression and usually not as severe as major...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Dysthymia is often characterized by chronic depression. Symptoms of dysthymia are the same as for depression and usually not as severe as major...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Dysthymia is often characterized by chronic depression. Symptoms of dysthymia are the same as for depression and usually not as severe as major...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Depression Treatment Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Depression Treatment Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Depression...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019 Summary Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Meniere Disease - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere...
Catalog:
Global Markets Direct
March 2019
Price: USD 2,000.00
Meniere Disease - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
Muscarinic Acetylcholine Receptor M4 - Pipeline Review, H2 2019 Summary Muscarinic Acetylcholine Receptor M4 (CHRM4) pipeline Target constitutes...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Baculoviral IAP Repeat Containing Protein 5 - Pipeline Review, H2 2019 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019 Summary...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H2 2019 Summary According to the recently published report 'Muscarinic Acetylcholine...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Systemic Mastocytosis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Meniere Disease - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere...
Catalog:
Global Markets Direct
February 2020
Price: USD 2,000.00
